Lrrk2 mutations in south america: a study of Chilean Parkinson's disease

被引:20
|
作者
Perez-Pastene, Carolina
Cobb, Stephanie A.
Diaz-Grez, Fernando
Hulihan, Mary A.
Miranda, Marcelo
Venegas, Pablo
Godoy, Osvaldo Trujillo
Kachergus, Jennifer M.
Ross, Owen A.
Layson, Luis
Farrer, Matthew J.
Segura-Aguilar, Juan
机构
[1] Univ Chile, Fac Med, ICBM, Programme Mol & Clin Pharmacol, Santiago 7, Chile
[2] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA
关键词
LRRK2; Parkinson's disease; mutation; Amerindian;
D O I
10.1016/j.neulet.2007.06.021
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Pathogenic substitutions in the leucine-rich repeat kinase 2 protein (Lrrk2), R1441G and G2019S, area prevalent cause of autosomal dominant and sporadic Parkinson's disease in the Northern Spanish population. In this study we examined the frequency of these two substitutions in 166 Parkinson's disease patients and 153 controls from Chile, a population with Spanish/European-Amerindian admixture. Lrrk2 R1441G was not observed, however Lrrk2 G2019S was detected in one familial and four sporadic Parkinson's disease patients. These findings suggest Lrrk2 G2019S may play an important role in Parkinson's disease on the South American Continent and further studies are now warranted. (c) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:193 / 197
页数:5
相关论文
共 50 条
  • [41] Identification of Three Novel LRRK2 Mutations associated with Parkinson's Disease in a Calabrian Population
    Anfossi, Maria
    Colao, Rosanna
    Gallo, Maura
    Bernardi, Livia
    Conidi, M. Elena
    Frangipane, Francesca
    Vasso, Franca
    Puccio, Gianfranco
    Clodomiro, Alessandra
    Mirabelli, Maria
    Curcio, Sabrina A. M.
    Torchia, Giusi
    Smirne, Nicoletta
    Di Lorenzo, Raffaele
    Maletta, Raffaele
    Bruni, Amalia C.
    JOURNAL OF ALZHEIMERS DISEASE, 2014, 38 (02) : 351 - 357
  • [42] Presynaptic dysfunction in Parkinson's disease: a focus on LRRK2
    Belluzzi, Elisa
    Greggio, Elisa
    Piccoli, Giovanni
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2012, 40 : 1111 - 1116
  • [43] LRRK2 contributes to monocyte dysregulation in Parkinson’s disease
    Corinna Bliederhaeuser
    Lisa Zondler
    Veselin Grozdanov
    Wolfgang P. Ruf
    David Brenner
    Heather L. Melrose
    Peter Bauer
    Albert C. Ludolph
    Frank Gillardon
    Jan Kassubek
    Jochen H. Weishaupt
    Karin M. Danzer
    Acta Neuropathologica Communications, 4
  • [44] The Upshot of LRRK2 Inhibition to Parkinson's Disease Paradigm
    Esteves, A. R.
    G-Fernandes, M.
    Santos, D.
    Januario, C.
    Cardoso, S. M.
    MOLECULAR NEUROBIOLOGY, 2015, 52 (03) : 1804 - 1820
  • [45] LRRK2 and membrane trafficking: nexus of Parkinson's disease
    Hur, Eun-Mi
    Jang, Eun-Hae
    Jeong, Ga Ram
    Lee, Byoung Dae
    BMB REPORTS, 2019, 52 (09) : 533 - 539
  • [46] LRRK2 and neuroinflammation: partners in crime in Parkinson's disease?
    Russo, Isabella
    Bubacco, Luigi
    Greggio, Elisa
    JOURNAL OF NEUROINFLAMMATION, 2014, 11
  • [47] The Upshot of LRRK2 Inhibition to Parkinson’s Disease Paradigm
    A. R. Esteves
    M. G-Fernandes
    D. Santos
    C. Januário
    S. M. Cardoso
    Molecular Neurobiology, 2015, 52 : 1804 - 1820
  • [48] LRRK2 Inhibitors as Promising Treatment for Parkinson's Disease
    Tan, Shuoyan
    Liu, Huanxiang
    Yao, Xiaojun
    ACS CHEMICAL NEUROSCIENCE, 2024, 15 (22): : 4092 - 4094
  • [49] Genetic Variants of LRRK2 in Taiwanese Parkinson's Disease
    Wu, Yih-Ru
    Chang, Kuo-Hsuan
    Chang, Wen-Teng
    Hsiao, Ya-Chin
    Hsu, Hsuan-Chu
    Jiang, Pei-Ru
    Chen, Yi-Chun
    Chao, Chih-Ying
    Chang, Yi-Chung
    Lee, Bo-Hsun
    Hu, Fen-Ju
    Chen, Wan-Ling
    Lee-Chen, Guey-Jen
    Chen, Chiung-Mei
    PLOS ONE, 2013, 8 (12):
  • [50] LRRK2 GTPase dysfunction in the pathogenesis of Parkinson's disease
    Xiong, Yulan
    Dawson, Valina L.
    Dawson, Ted M.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2012, 40 : 1074 - 1079